Background illustration for clinical trials search

Paid Clinical Trials Chandler

Discover 1,294 paid clinical trials in Chandler, Arizona. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Randomised Clinical Trial to Investigate Efficacy and Safety of Benralizumab 30 mg SC as an add-on Therapy in Uncontrolled Eosinophilic Asthma Patients Treated With Medium-dose ICS-LABA Compared to Conventional Escalation to High-dose ICS-LABA Treatment

for
Eosinophilic Asthma
Location: Sun City AZ, Tucson AZ, Henderson NV, Newport Beach CA,
Sponsor: AstraZeneca

Sex: All

Age: 12 - 70+

Code: NCT06750289

Phase 3, Recruiting

Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial

for
Anatomic Stage IV Breast Cancer AJCC v8,
Location: Phoenix AZ, San Diego CA, La Jolla CA, Encinitas CA,
Sponsor: NRG Oncology

Sex: All

Age: 18+

Code: NCT06500481

Phase 3, Recruiting

Highly Selective CDK7 Inhibitor Q901 in Selected Advanced Solid Tumors

for
Advanced Cancer, Metastatic Cancer
Location: Phoenix AZ, Los Angeles CA, Dallas TX, Rochester MN,
Sponsor: Qurient Co., Ltd.

Sex: All

Age: 18+

Code: NCT05394103

Phase 1, Phase 2, Recruiting

A US Non-interventional, Effectiveness and Safety Study of Patients Treated With SKYTROFA

for
Growth Hormone Deficiency
Location: Phoenix AZ, Las Vegas NV, El Paso TX, Orange CA,
Sponsor: Ascendis Pharma Endocrinology Division A/S

Sex: All

Age: 0+

Code: NCT05820672

Recruiting

DAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With Small Cell Lung Cancer or Other Neuroendocrine Cancers

for
Small Cell Lung Carcinoma, Neuroendocrine Neoplasms,
Location: Phoenix AZ, Los Angeles CA, San Francisco CA,
Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT05882058

Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Chronic Subdural Hematoma Treatment With Embolization Versus Surgery Study

for
Chronic Subdural Hematoma
Location: Phoenix AZ, Salt Lake City UT, San Antonio TX,
Sponsor: The University of Texas Medical Branch, Galveston

Sex: All

Age: 40 - 70+

Code: NCT06347796

Recruiting

An Open-Label, Multiple-Center, Phase IIa/IIb Clinical Trial to Evaluate the Efficacy, Safety and Tolerability of VG161 as Monotherapy and in Combination With Nivolumab for Treatment of Patients With Hepatocellular Carcinoma or Intrahepatic Cholangiocarcinoma

for
Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma
Location: Phoenix AZ, Rochester MN, Jacksonville FL
Sponsor: Virogin Biotech Canada Ltd

Sex: All

Age: 18+

Code: NCT05223816

Phase 2, Recruiting

Safety and Device Performance of the Uriprene® Degradable Temporary Ureteral Stent Following Uncomplicated Ureteroscopy

for
Ureteral Diseases
Location: Phoenix AZ, Los Angeles CA, Columbus OH, Gainesville FL
Sponsor: Adva-Tec

Sex: All

Age: 21 - 70+

Code: NCT04565795

Recruiting

Expanding Liver Transplant Immunosuppression Minimization Via Everolimus

for
Liver Transplant
Location: Phoenix AZ, San Francisco CA, Dallas TX, Chicago IL,
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All

Age: 18+

Code: NCT06280950

Phase 2, Recruiting

A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinations in Participants With Relapsed and/or Refractory Multiple Myeloma

for
Multiple Myeloma
Location: Phoenix AZ, Duarte CA, Houston TX, Omaha NE, Calgary,
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company

Sex: All

Age: 18+

Code: NCT06121843

Phase 1, Recruiting

A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies

for
Advanced or Metastatic Solid Tumors, Breast Cancer,
Location: Phoenix AZ, Salt Lake City UT, Houston TX, Seattle WA,
Sponsor: 858 Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06395519

Phase 1, Phase 2, Recruiting

Testing Teclistamab (TECVAYLI) in Combination With Iberdomide for Relapsed or Refractory Multiple Myeloma

for
Recurrent Multiple Myeloma, Refractory Multiple Myeloma
Location: Phoenix AZ, Oklahoma City OK, Overland Park KS,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06465316

Phase 1, Recruiting

Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)

for
Prostate Cancer,
Location: Phoenix AZ, Newport Beach CA, Los Angeles CA,
Sponsor: Janux Therapeutics

Sex: Male

Age: 18 - 70+

Code: NCT05519449

Phase 1, Recruiting

Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform

for
Early Stage Triple-Negative Breast Carcinoma,
Location: Phoenix AZ, Rochester MN, Jacksonville FL
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT06349642

Recruiting

Biologically-Adapted, Dose-Escalated Radiotherapy for the Treatment of Ewing Sarcoma, BEAR Trial

for
Ewing Sarcoma, Round Cell Sarcoma With EWSR1-non-ETS Fusion
Location: Phoenix AZ, Rochester MN
Sponsor: Mayo Clinic

Sex: All

Age: 2+

Code: NCT07188532

Recruiting

A Study of CTX-712 in Relapsed/Refractory Acute Myeloid Leukemia and Higher Risk Myelodysplastic Syndromes

for
Acute Myeloid Leukemia, Myelodysplastic Syndromes
Location: Phoenix AZ, Houston TX, Seattle WA, Rochester MN,
Sponsor: Chordia Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT05732103

Phase 1, Phase 2, Recruiting

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

for
Acute Myeloid Leukemia, Mixed Lineage Leukemia Gene Mutation,
Location: Phoenix AZ, La Jolla CA, Orange CA, Los Angeles CA,
Sponsor: Kura Oncology, Inc.

Sex: All

Age: 18+

Code: NCT05735184

Phase 1, Recruiting

Product Surveillance Registry

for
Cardiac Rhythm Disorders, Urological Disorders,
Location: Chandler AZ, Phoenix AZ, Chula Vista CA, San Diego CA,
Sponsor: Medtronic

Sex: All

Age: 0+

Code: NCT01524276

Recruiting

CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.

for
Epithelial Ovarian Cancer, Primary Peritoneal,
Location: Phoenix AZ, Tucson AZ, Fullerton CA, Duarte CA,
Sponsor: TORL Biotherapeutics, LLC

Sex: Female

Age: 18+

Code: NCT06690775

Phase 2, Recruiting

(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis

for
Advanced Systemic Mastocytosis (AdvSM),
Location: Phoenix AZ, Duarte CA, Los Angeles CA,
Sponsor: Cogent Biosciences, Inc.

Sex: All

Age: 18+

Code: NCT04996875

Phase 2, Recruiting